Tianhong Li MD, PhD

Dr. Tianhong “Tina” Li is a medical oncologist in the Department of Internal Medicine, Division of Hematology/Oncology at the University of California at Davis (UC Davis). Dr. Li’s research mainly focuses on understanding the mechanisms of action of novel targeted agents and developing rational therapeutic strategies for breast and lung cancer. Currently, she serves as co-director of the Phase I program at UC Davis Comprehensive Cancer Center.
She has clinical and laboratory expertise in lung and breast cancer research. She also serves as UC Davis site co-Principal Investigator for the UC-wide ATHENA breast health multi-campus research initiative. She is an active member of California Cancer Consortium and Southwest Oncology Group (SWOG), and serves in the Membership Committee of International Association for the Study of Lung Cancer (2012-2014).
Dr. Li obtained her MD degree from Peking University Health Science Center (formerly Beijing Medical University) in China in 1989 and PhD in Molecular Immunology from Loyola University, Chicago, Illinois in 1996. She pursued resident training in Internal Medicine at the Beth Israel Medical Center and a Hematology/Oncology fellowship at Montefiore Medical Center, Albert Einstein College of Medicine in the Bronx, New York. She was subsequently recruited there as a faculty member until she moved to her current position at University of California at Davis in 2009. She is Board Certified in Hematology and Medical Oncology.